+ 1 888 391 5441
Sort By
Title Published Price Buy Now
Investigation Report on China Thrombin Market, 2010-2019
By China Research and Intelligence
Anticoagulant, including various products, is mainly used to prevent blood clotting. It will also be used when patients need to connect to some medical instruments or receive blood transfusions or when their blood needs to be sent for testing. Thr...
Jun 2015 $ 2000
Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market, 2010-2019
By China Research and Intelligence
Piperacillin sodium and tazobactam sodium is the compound drug of piperacillin sodium and tazobactam sodium, the former being semisynthesized broadspectrum penicillin while the latter being ?lactamase inhibitor. Tazobactam sodium can prevent piper...
Jun 2015 $ 2000
Global and China Industrial Enzyme Industry Report, 2014-2017
By Research In China
In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzyme market is basically an oligopoly. In 2014, No...
Jun 2015 $ 2000
Investigation Report on China Etanercept Market, 2010-2019
By China Research and Intelligence
There are over 300 million people suffering from arthritis around the world. According to the statistics of Centers for Disease Control and Prevention (CDC), about 50 million American suffer from arthritis and this number will rise to 67 million i...
Jun 2015 $ 2000
Investigation Report on China Trastuzumab Market, 2010-2019
By China Research and Intelligence
Monoclonal antibody, an epochal drug variety, plays an important role in the upgrading process of treatments for tumor and autoimmune disease, and has become a mainstream in the global market of targeting therapeutic agents. The manufacturers of a...
Jun 2015 $ 2000
Investigation Report on China Telmisartan Market, 2010-2019
By China Research and Intelligence
The number of hypertension patients in China is estimated to surpass 300 million with one in three adults suffering from it. Out of all the dyazides, angiotension receptor blocker (ARB) is among a new generation which grows fast. Ever sinc...
Jun 2015 $ 2000
Investigation Report on China Entecavir Market, 2010-2019
By China Research and Intelligence
The number of people infected with hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatitis B. About 0.5 million Chinese is estimated to die of liver damage and liver cancer caused by chronic...
Jun 2015 $ 2000
Investigation Report on China Progesterone Market, 2010-2019
By China Research and Intelligence
The clinical demand for steroid drug is increasing fast due to its wide application and good efficacy especially its extended use in regulating human endocrine and slowing down ageing in recent years. Progesterone, a natural progestogen pr...
Jun 2015 $ 2000
Investigation Report on China Cefathiamidine Market, 2010-2019
By China Research and Intelligence
Developed by Guangzhou Baiyunshan Pharmaceutical General Factory, cefathiamidine has been written into the Chinese Pharmacopoeia (2005). Ever since its marketing in 2000, the sales value of cefathiamidine has risen from less than CNY 100 million i...
Jun 2015 $ 2000
Investigation Report on China Bromhexine Market, 2010-2019
By China Research and Intelligence
As air pollution worsens, the incidence of respiratory disease keeps growing and so does the market size of relevant drugs. Bromhexine, a semisynthetic derivative of vasicine, is a mucolytic agent used in the treatment of chronic bronchitis and as...
Jun 2015 $ 2000
Investigation Report on China Flurbiprofen Market, 2010-2019
By China Research and Intelligence
Non-steroidal anti-inflammatory drug (NSAID) has a totally different chemical structure from steroids which have a similar anti-inflammatory antirheumatic action. NSAID can also provide analgestic and antipyretic effects with fewer side effects co...
Jun 2015 $ 2000
Investigation Report on China Ganglioside Market, 2010-2019
By China Research and Intelligence
Cardia-cerebrovascular disease is the first big disease with a mortality rate of 20% in the world and over 40% in China. Besides, as most cardia-cerebrovascular diseases are chronic diseases, long-term treatment is needed, which has forced the big...
Jun 2015 $ 2000
Investigation Report on China Salmon Calcitonin Market, 2010-2019
By China Research and Intelligence
China has become the country with the largest number of osteoporosis patients. A nationwide large-scale epidemiological survey has also shown that the incidence of osteoporosis in China has exceeded 12% and that this figure among elders is over 50...
Jun 2015 $ 2000
Investigation Report on China Moxifloxacin Market, 2010-2019
By China Research and Intelligence
As the fourth generation of quinolones drugs, moxifloxacin (moxifloxacin hodrochloride) was first introduced to the market by The Bayer Group in Sep. 1999. It is utilized in the treatment of adult patients (aged 18 and above) diagnosed with upper ...
Jun 2015 $ 2000
Investigation Report on China Levothyroxine Market, 2010-2019
By China Research and Intelligence
Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones mainly promote the growth and development of bones, brain and reproductive organs, even the growth hormone (GH) o...
Jun 2015 $ 2000
Investigation Report on China Menotropins Market, 2010-2019
By China Research and Intelligence
According to the statistics, at present there are about 100 million women in the high-fertility period (aged 20-29) in China, over 12% of whom suffer from infertility. About 30% of female diagnosed with infertility suffer from ovulation inhibition...
Jun 2015 $ 2000
Investigation Report on China Ossotide Market, 2010-2019
By China Research and Intelligence
According to statistics, the incidence of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of degraded joint function, is also common to see. With the ageing pop...
Jun 2015 $ 2000
Investigation Report on China Rosuvastatin Market, 2010-2019
By China Research and Intelligence
First developed by Shionogi Inc. under the code name of S-4522 at the end of 1980s, rosuvastatin (rosuvastatin calcium) along with its development, marketing and sales rights, was transferred to AstraZeneca in Jun. 1998 under the code name of ZD-4...
Jun 2015 $ 2000
Investigation Report on China Glucosamine Market, 2010-2019
By China Research and Intelligence
Osteoarthritis (OA) is a kind of chronic degenerative disease, and it is also the commonest arthritis in the clinic. The lesion is a slow yet progressing process. Major symptoms include wearing away and damage of articular cartilage, whereas clini...
Jun 2015 $ 2000
Investigation Report on China Liraglutide Market, 2011-2019
By China Research and Intelligence
Description As economy develops and living standards improve, Chinese people's dietary pattern changes, resulting in excess heat. Meanwhile, the drop in physical activities leads to the increased obesity rate. Other factor...
Jun 2015 $ 2000
Investigation Report on China Capecitabine Market, 2010-2019
By China Research and Intelligence
Description Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in 2 years. In ...
Jun 2015 $ 2000
Investigation Report on China Tacrolimus Market, 2010-2019
By China Research and Intelligence
Description Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus...
Jun 2015 $ 2000
Investigation Report on China Recombinant Factor VIII Market, 2010-2019
By China Research and Intelligence
Description Hemophilia is a hereditary bleeding disorder caused by a lack of clotting factor VIII or IX, though not rare, which affects mostly males. Hemophilia A (clotting factor VIII deficiency) is the most common form o...
Jun 2015 $ 2000
Investigation Report on China Atorvastatin Market, 2010-2019
By China Research and Intelligence
Description With the change of life styles brought about by the economic development and the rising incomes, the number of hyperlipidemia patients in China keeps growing, being estimated to reach 160-200 million in the nea...
Jun 2015 $ 2000
Investigation Report on China Insulin Lispro Market, 2010-2019
By China Research and Intelligence
Description According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382 million i...
Jun 2015 $ 2000
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy